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Abstract
We make use of ideas from the theory of complex networks to implement a machine learn-
ing classification of human DNA methylation data, that carry signatures of cancer develop-
ment. The data were obtained from patients with various kinds of cancers and represented
as parenclictic networks, wherein nodes correspond to genes, and edges are weighted
according to pairwise variation from control group subjects. We demonstrate that for the 10
types of cancer under study, it is possible to obtain a high performance of binary classifica-
tion between cancer-positive and negative samples based on network measures. Remark-
ably, an accuracy as high as 93−99% is achieved with only 12 network topology indices, in a
dramatic reduction of complexity from the original 15295 gene methylation levels. Moreover,
it was found that the parenclictic networks are scale-free in cancer-negative subjects, and
deviate from the power-law node degree distribution in cancer. The node centrality ranking
and arising modular structure could provide insights into the systems biology of cancer.
Introduction
Epigenetic information is stored in a genome in the form of heritable modifications to the
chemical structure of DNA, such as methylation of CpG di-nucleotides, and a number of
chemical modifications of histone proteins. It can be modulated during the lifetime of an
organism by environmental signals [1–3], and these changes persist in subsequent mitoses, as
an acquired change of phenotype. However, besides the fundamental role of epigenetics in
mediating environmental effects on the genome, it leaves a backdoor for environmental risk
factors.
In particular, variations in DNA methylation (DNAm) accompany the early stages of
human carcinogenesis [1], and could, therefore, manifest as quantitative signatures of such ill-
nesses or as a risk of their development [4–7]. Due to the huge number of individual CpG sites
(of the order of 105) at which methylation levels are assessed, there is a substantial interest in
developing aggregate measures, so as to reduce the dimension of the mathematical problem,
whilst still taking account of the key genomic effects of cancer.
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Recently, it has been demonstrated that gene-specific measures of DNA methylation, such as
mean, variance, mean derivative and suchlike reflect cancer-related changes and enable differ-
entiation between normal and tumour tissue samples [8]. Furthermore, a method to construct a
network representation of the data was proposed, with genes taken as nodes. Edge weights then
quantify the extent to which the methylation profiles of these genes covary in the same way as
the healthy population profiles do [9]. Some edges of this network representation were shown
to be associated with survival outcome for patients with different types of cancer. It was also
found that natural groupings of these prognostic edges could be identified as subnetwork mod-
ules, relevant to a number of biological functions. This indicated that epigenetic network mod-
els and measures do not just technically reduce the complexity of a computational problem, but
naturally reflect intrinsic collective behaviour and interactions of such groups of genes.
Inspired by these findings, we address the problem of constructing epigenetic data net-
works and identifying network measures for distinguishing between normal and cancer cells.
We seek a solution implementing recently developed parenclitic network analysis [10, 11].
This approach identifies generic biomedical measurements with nodes and specifies that an
edge exists between each pair of nodes if their values for a particular subject are significantly
different from the linear regression model for a control “healthy” group (or weight of the edge
is proportional to the mismatch of the regression model). In result one obtains a network for
each subject, which properties are expected to be different in health and disease.
We demonstrate that parenclictic networks built on DNAm data correctly represent source
data, therefore classifiers based on routine network measures (average node degree, diameter,
etc.) can produce approximately 93−99% accuracy. The statistics of parenclictic networks for
healthy tissues exhibits power-law tails in the node-degree distributions, that indicates sub-
stantial natural fluctuations in methylation levels. Remarkably, cancer modifications in
DNAm induce a qualitative change in network topology: heavy-tailed too, they show marked
deviations from power-law scaling. Exceptions are found in one case only, where the network
architecture does not change noticeably and at the same time the performance of the respective
classifier drops to about 90%.
Methods
Data
Methylation data, collected via the Illumina Infinium Human Methylation 450 platform, were
downloaded from The Cancer Genome Atlas (TCGA) project [12] at level 3. Data were
obtained from ten different healthy and tumour tissues: Bladder Urothelial Carcinoma
(BLCA), Breast Invasive Carcinoma (BRCA), Colon Adenocarcinoma (COAD), Head and
Neck Squamous Cell Carcinoma (HNSC), Kidney Renal Clear Cell Carcinoma (KIRC), Kidney
Renal Papillary Cell Carcinoma (KIRP), Lung Adenocarcinoma (LUAD), Prostate Adenocar-
cinoma (PRAD), Thyroid Carcinoma (THCA), and Uterine Corpus Endometrioid Carcinoma
(UCEC). The number of samples for each data set is shown in Table 1. Raw data were pre-pro-
cessed as described in [8], briefly summarised as follows. First, probes were removed if they
have non-unique mappings or map to SNPs (as identified in the TCGA level 3 data); probes
mapping to sex chromosomes were also removed; in total 98384 probes were removed in this
way from all data sets. After removal of these probes, 270985 probes with known gene annota-
tions remained. Individually for each data set, probes were then removed if they had less than
95% coverage across samples; probe values were also replaced if they had corresponding detec-
tion p-value greater than 5%, by KNN (k nearest neighbour) imputation (k = 5). Methylation
level has been considered across the whole gene, as a way of simplifying the large quantity of
data. And whilst some information will undoubtedly be lost by rescaling all methylation values
Parenclitic Network Analysis of Methylation Data
PLOS ONE | DOI:10.1371/journal.pone.0169661 January 20, 2017 2 / 11
(network statistics analysis). Computations were
carried out on the Lobachevsky University
supercomputer. The funders had no role in study
design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing Interests: The authors have declared
that no competing interests exist.
into range [0, 1] and characterising each gene by the average level of methylation, we still
found that changes in methylation level across the whole gene were indicative of disease. In
future work, it will be important to refine the analysis by considering mean methylation across
specific functional regions within the gene, such as the promoter, the first exon, et cetera. The
total number of genes of interest was 15295.
Construction of networks
We utilize the parenclictic network approach [10, 11] in order to construct and analyze graphs
from gene methylation data. The resulting network is a complete weighted graph: each vertex
corresponds to a specific gene, and edge weight is proportional to the variation of methylation
levels in specific gene pair in cancer-positive and negative phenotypes. The procedure is aimed
at unveiling hidden relations between methylation levels of gene pairs and discovery of global
dependencies.
The procedure originally applied to different biomedical data [10, 11] includes the follow-
ing steps:
1. Select a control group from healthy tissue samples.
2. Adjust methylation levels for each pair of genes, mi and mj, to a linear regression based on
the control group subjects:
mj ¼ ai;j þ bi;jmi; ð1Þ
where αi, j and βi, j are regression coefficients.
3. Build complete weighted graph for each cancer-positive and negative sample, excluding the
control group, such that each vertex corresponds to a particular gene, and edges are
weighted according to
wi;j ¼
jxj   ðai;j þ bi;jxiÞj
si;j
; ð2Þ
where xi and xj are respective methylation levels, and σi, j is the standard deviation of errors
in the linear regression model for control objects Eq (1).
This process is illustrated in Fig 1 through the use of the two genes ZFP106 and NEUROD1
for BRCA data. Each point corresponds to gene methylation levels in the control group
Table 1. Number of samples obtained from normal tissue (healthy subjects) and tumour tissue (can-
cer subjects), see the text for abbreviations. The data were downloaded from TCGA portal.
Type of cancer Number of healthy subjects Number of cancer subjects
BLCA 18 126
BRCA 98 586
COAD 38 258
HNSC 50 310
KIRC 160 283
KIRP 50 98
LUAD 32 306
PRAD 49 176
THCA 50 357
UCEC 36 334
doi:10.1371/journal.pone.0169661.t001
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(green), and other BRCA-negative (blue) and BRCA-positive (red) subjects. The data points
for the subjects with the disease are substantially more distant from the linear regression
model (solid line), as compared to the data points for the healthy ones. Thus at least some of
the edge weights in the parenclictic networks for the former group will be considerably greater,
potentially introducing detectable modifications in global network characteristics [10, 11].
Linear regression approach is quite clear and gives good results in many cases. However, at
least for data of interest, it does not always yield a decent estimation of the closeness between
the control and cancer subjects. Indeed, changing one of the genes in the example above, that
is, considering ZFP106 and TRIM9 methylation levels in BRCA data, we find that all three of
the clusters (control, BRCA-negative and positive) match the linear regression model (1) well
(see Fig 2). Consequently, for all sample classes the ZFP106-TRIM9 edge weights Eq (2) will,
typically, be relatively small and of the same order of magnitude. At the same time, the BRCA-
negative and positive clusters are visibly distinct.
To overcome this problem we implement the Mahalanobis distance [13], which, essentially,
measures separation between data sets. In particular, instead of Eq (2) the edge weight wi, j is
caclulated as:
wi;j ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
ðxi;j   mi;jÞ
TS  1i;j ðxi;j   mi;jÞ
q
; ð3Þ
where, as before, xi and xj are gene methylation levels in an investigated sample, μi and μj are
the gene methylation levels in the control group, xi, j = (xi, xj), μi, j = (E(mi),E(mj)), and Si, j =
cov(mi, mj). In this way, the abnormal modifications in methylation of gene pairs are better
captured, which, in turn, improves sample classification accuracy for our data by 1−3%.
Metrics of network topology
The massive number of edges in constructed graphs makes a straightforward solution of
machine learning classification problem intractable in practice, also manifesting a huge imbal-
ance between the number of features and available samples. Therefore, we utilize a number of
Fig 1. Determining the edge weight between ZFP106 and NEUROD1 genes. Each point corresponds to gene methylation
levels in the control group (green), other BRCA-negative (blue) and BRCA-positive (red) subjects. The solid line shows the
linear regression model (1). The mismatch to Eq (2) is, in general, a good discriminator between healthy and tumour samples.
doi:10.1371/journal.pone.0169661.g001
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topology metrics, widely used for characterising complex networks [14–16], appropriately gen-
eralised for weighted graphs G≔ (V, E) with |V| vertices and |E| edges:
• Node degree deg(v) as the sum of incidental edges weights.
• The distance d(vi, vj) between the nodes vi, j 2 V, defined as the sum of the edge weights in
the shortest path.
• The diameter of the graph G as the maximal distance between a pair of vertices.
• The degree centrality CD(G) of the graph G defined as the normalised graph degree centrality
H(G)
CDðGÞ ¼
HðGÞ
Hmax
; ð4Þ
which is
HðGÞ ¼
XjVj
i¼1
jCDðv
Þ   CDðviÞj; ð5Þ
based on the node degree centrality CDðvÞ ¼
degðvÞ
jVj , and where v
 is the node with the maxi-
mal degree centrality, and Hmax = (|V| − 1)(|V| − 2) is the maximal graph degree centrality,
obtained for the star topology.
• Graph efficiency EC(G) defined as [17]
ECðGÞ ¼
CCðGÞ
jVjðjVj   1Þ
; ð6Þ
Fig 2. Determining the edge weight between ZFP106 and TRIM9 genes. Each point corresponds to gene methylation
levels in the control group (green), other BRCA-negative (blue) and BRCA-positive (red) subjects. The solid line shows the
linear regression model (1). While the data sets for healthy and tumour samples are quite distinct, the mismatch Eq (2) is of the
same order of magnitude for both classes. Employing the Mahalanobis distance Eq (3) overcomes this problem.
doi:10.1371/journal.pone.0169661.g002
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based on the graph centrality measure
CCðGÞ ¼
X
i6¼j
1
dðvi; vjÞ
: ð7Þ
• Betweenness centrality CB(vk) of a node as the number of the shortest paths the particular
node vk belongs to:
CBðvkÞ ¼
X
k6¼i6¼j
svi ;vjðvkÞ
svi;vj
; ð8Þ
where σvi,vj is the number of the shortest paths between the nodes vi and vj, among which
σvi,vj(vk) passing through vk.
These quantities in one way or another should reflect the expected differences between the
sample classes. For instance, increasing separation of data sets produces greater edge weights
and may result in substantial decrease of the graph diameter. Likewise, nodes with large cen-
trality scores signify their key role is class distinguishing and give us a hint at biological
importance.
Results and Discussion
As we can see from the examples of the pairwise gene methylation level diagrams, there exists
intrinsic variability in both healthy and tumour tissue samples (see Figs 1 and 2). Therefore,
parenclictic networks built from both data classes should have random-like and complex
structure. To get a general idea on the appearance of the resulting networks, we present indica-
tive examples of BRCA-positive and negative donors, plotting the 1000 edges with largest
weights and incident nodes (Fig 3). Remarkably, for cancer subjects they typically comprise
several star-type subgraphs, with the most abnormally methylated genes as vertices. At the
same time, healthy subjects yield considerably more homogeneous networks.
Fig 3. Typical examples of parenclictic networks constructed from gene methylation profiles for cancer (left) and
normal (right) samples from BRCA data. Only a 1000 of the strongest edges and their incident nodes are shown. Note the
pronounced modular structure for the cancer network.
doi:10.1371/journal.pone.0169661.g003
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Distinguishing between cancer-positive and negative DNAm profiles is implemented by
standard machine learning classification algorithms, namely, Support Vector Machine (SVM)
and Random Forest (RF) [18, 19]. The binary classifiers are trained on 12 topological indices
calculated for parenclictic networks as described in Methods:
• mean, variation and maximal values of edge weights,
• mean, variation and maximal values of vertex degree,
• mean and variation of shortest path lengths,
• diameter of graph,
• degree centrality,
• efficiency,
• and betweenness centrality.
In addition, RF was also trained on the original gene average methylation level data. All
code was written in Python 3. For classification we have used Python scikit-learn package.
In order to assess the performance of our classifiers we used the two-step cross-validation
technique. The first step included cross-validation for selecting a control group from healthy
tissue samples. For data sets where the number of healthy subjects was less than 50 instances,
we applied 2-fold cross-validation; otherwise, 4-fold cross-validation was used. The second
step involved factual 10-fold cross-validation for every data set with topology indices.
Limited by the amount of data, we couldn’t make use of AUC as a classification metrics.
Indeed, a quarter or a half of healthy patients data were put aside after the first cross-validation
step. During the 10-fold cross-validation at the second step, the data were divided further and,
after all, each fold contained one or two healthy patients at best. In result, AUC could be calcu-
lated in rare cases only.
The results, summarized in Tables 2 and 3, demonstrate an excellent performance of classi-
fiers trained on network measures for almost all kinds of cancer, with accuracy in the range 93
−99%. Interestingly, the performance does not manifest any considerable dependence on the
type of classification algorithm in most cases, with the only noticeable dissimilarity of RF
observed for BRCA, PRAD and THCA groups. We suggest that the accuracy of classification
would not depend strongly on the particular choice of machine learning algorithm.
Table 2. Classification accuracy of RF machine learning algorithm trained on topology indices of parenclictic networks, along with the RF perfor-
mance on the original gene average methylation level data for different types of cancer.
Classification with topology indices Classification with gene methylation
Cancer Accuracy Specificity Sensitivity Accuracy Specificity Sensitivity
BLCA 95.89% 77.77% 99.19% 95.95% 66.66% 98.38%
BRCA 96.96% 91.87% 98.11% 97.82% 87.67% 98.96%
COAD 99.30% 94.73% 100.00% 99.33% 94.73% 100.00%
HNSC 96.70% 85.57% 98.69% 98.60% 92.27% 99.36%
KIRC 98.63% 98.75% 98.92% 98.90% 98.62% 98.14%
KIRP 99.17% 97.72% 100.00% 96.03% 95.89% 95.80%
LUAD 99.43% 93.75% 99.01% 99.39% 93.72% 100.00%
PRAD 90.40% 71.58% 89.65% 92.58% 85.12% 94.76%
THCA 93.12% 70.03% 96.60% 94.33% 71.90% 97.40%
UCEC 98.62% 91.67% 99.10% 99.20% 91.67% 100.00%
doi:10.1371/journal.pone.0169661.t002
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Comparing performance of the RF classifier built on the network measures and the original
average methylation levels of 15295 genes, we do not notice systematic weaknesses of the latter.
Moreover, in some cases, using network measures enhances classification results. Except for
the case with PRAD, which we will discuss hereinafter, the network measures seem to incorpo-
rate cancer modifications of gene methylation levels very well, and the substantial reduction of
the complexity of classification task does not impair the resulting accuracy. Another benefit of
implementing classification on network measures is that in this case the number of features is
considerably smaller than the number of samples, which prevents overfitting.
Let us investigate it in more detail, why the performance of the network measure classifiers
for PRAD is slightly poorer, at about 87−90%. Clearly, the answer must be sought in the less
pronounced differences between the classes in the global network characteristics. To get a
deeper insight we analysed the node degree distributions for parenclictic networks constructed
from the data, corresponding to different types of cancer. Remarkably, the results consistently
revealed that for cancer-negative subjects the networks are scale-free, with the complementary
cumulative degree distributions closely following a power-law (see Fig 4 for representative
cases). On the contrary, parenclictic networks for cancer-positive subjects demonstrate pro-
nounced deviations from power-law scaling, except for PRAD, where the node degree statistics
does not change significantly and network measures give worse classification accuracy (Fig 4).
This suggests that the further work here should primarily focus on modifying the network con-
struction method itself, rather than introducing other network measures.
Conclusions
We demonstrated that the parenclictic network approach can be successfully implemented in
order to obtain graph representations of gene methylation levels for cancer-positive and nega-
tive subjects. These graphs can be characterised by 12 global network measures, which provide
a basis for binary classification by routine machine learning algorithms, Support Vector
Machine and Random Forest. For almost all cancer types the performance of both algorithms
remains much the same so that the particular choice does not seem crucial.
Comparing to performance of Random Forest classifier built on the original average meth-
ylation levels of 15295 genes does not reveal a substantial difference, with the accuracy reach-
ing 90−99% for all the types of cancer. This means that a cardinal reduction to 12 features,
topological indices, does not lead to the loss of important information. Yet another strong ben-
efit of the considerably decreased complexity is the avoidance of overfitting, which could be a
Table 3. Classification accuracy of SVM algorithm trained on topology indices of parenclictic networks, along with the RF performance on the orig-
inal gene average methylation level data for different types of cancer.
Classification with topology indices Classification with gene methylation
Cancer Accuracy Specificity Sensitivity Accuracy Specificity Sensitivity
BLCA 95.89% 77.78% 98.39% 95.95% 66.66% 98.38%
BRCA 93.62% 83.33% 95.21% 97.82% 87.67% 98.96%
COAD 99.33% 94.74% 100.00% 99.33% 94.73% 100.00%
HNSC 95.89% 84.62% 97.40% 98.60% 92.27% 99.36%
KIRC 96.36% 95.00% 97.14% 98.90% 98.62% 98.14%
KIRP 98.75% 100.00% 97.62% 96.03% 95.89% 95.80%
LUAD 99.41% 93.75% 100.00% 99.39% 93.72% 100.00%
PRAD 87.40% 61.33% 94.82% 92.58% 85.12% 94.76%
THCA 96.09% 84.62% 97.73% 94.33% 71.90% 97.40%
UCEC 98.39% 88.89% 99.40% 99.20% 91.67% 100.00%
doi:10.1371/journal.pone.0169661.t003
Parenclitic Network Analysis of Methylation Data
PLOS ONE | DOI:10.1371/journal.pone.0169661 January 20, 2017 8 / 11
serious problem when using the original 15295 gene methylation levels as features, due to the
relatively small number of samples.
Finally, network analysis does not only allow identifying cancer methylation profiles but
provides additional insight into the systems biology of cancer. That is, the nodes with high cen-
trality are good candidates for playing a significant role in cancer development. Strong devia-
tions from scale-free node degree distributions for almost all cancer types is a hallmark of the
global changes in the network topology induced by cancer, which remains to be understood.
Another open question is the modular properties of the arising parenclictic networks, observed
by naked eye inspection, and their correspondence to biological functions.
Fig 4. Average complementary cumulative node degree distribution (the fraction of nodes, for which the degree
exceeds a given value) for HNSC (top) and PRAD (bottom) subjects. Green lines on the log-log plots display the power-law
model best fit.
doi:10.1371/journal.pone.0169661.g004
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